Immature platelets in patients with Covid-19: association with disease severity
Journal of Thrombosis and Thrombolysis · 2021-10 · 52 (3) · 708-714
DOI: 10.1007/s11239-021-02560-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Thrombolysis, online erschienen am 14.09.2021. Verfasst von Amir Cohen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Coronavirus disease 2019 (Covid-19) is associated with a high incidence of venous and arterial thromboembolic events. Currently, there are no clinical or laboratory markers that predict thrombotic risk. Circulating immature platelets are hyper-reactive platelets, which are associated with arterial thrombotic events. The aim of this study was to assess whether the proportion of circulating immature platelets is associated with disease severity in Covid-19 patients. Patients admitted with Covid-19 disease were prospectively assessed. Immature platelet count (IPC) and immature platelet fraction (IPF) were measured at admission and at additional time points during the hospital course using the Sysmex XN-3000 auto-analyzer. A total of 136 consecutive patients with Covid-19 were recruited [mean age 60 ± 19 years, 49% woman, 56 (41%) had mild-moderate disease and 80 (59%) had severe disease at presentation]. The median IPF% was higher in patients with severe compared to mild-moderate disease [5.8 (3.9-8.7) vs. 4.2 (2.73-6.45), respectively, p = 0.01]. The maximal IPC value was also higher in patients with severe disease [15 (10.03-21.56), vs 10.9 (IQR 6.79-15.62), respectively, p = 0.001]. Increased IPC was associated with increased length of hospital stay. Patients with severe Covid-19 have higher levels of IPF than patients with mild-moderate disease. IPF may serve as a prognostic marker for disease severity in Covid-19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel.
- The Faculty of Health Sciences, Ben-Gurion University, Be'ersheba, Israel.
- Laboratory Division, Assuta Ashdod Medical Center, Ashdod, Israel.
- Intensive Care Department, Assuta Ashdod Medical Center, Ashdod, Israel.
- Cardiology Department, Assuta Ashdod Medical Center, Ashdod, Israel. elil@assuta.co.il.
- The Faculty of Health Sciences, Ben-Gurion University, Be'ersheba, Israel. elil@assuta.co.il.
Zitieren
APA
Cohen, A., Harari, E., Yahud, E., Cipok, M., Bryk, G., Lador, N. K., Mann, T., Mayo, A., & Lev, E. I. (2021). Immature platelets in patients with Covid-19: association with disease severity. Journal of Thrombosis and Thrombolysis, 52(3), 708-714. https://doi.org/10.1007/s11239-021-02560-x
Vancouver
Cohen A, Harari E, Yahud E, Cipok M, Bryk G, Lador NK, et al. Immature platelets in patients with Covid-19: association with disease severity. Journal of Thrombosis and Thrombolysis. 2021;52(3):708-714. doi:10.1007/s11239-021-02560-x
BibTeX
@article{Cohen2021,
author = {Cohen, Amir and Harari, Emanuel and Yahud, Ella and Cipok, Michal and Bryk, Gabriel and Lador, Nili Karp and Mann, Tal and Mayo, Ami and Lev, Eli I},
title = {Immature platelets in patients with Covid-19: association with disease severity},
journal = {Journal of Thrombosis and Thrombolysis},
year = {2021},
volume = {52},
number = {3},
pages = {708--714},
doi = {10.1007/s11239-021-02560-x}
}
EUVIMED